{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:24:07Z","timestamp":1793247847932,"version":"4.5.0"},"reference-count":184,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020699","name":"Dongil Culture and Scholarship Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2020R1A5A2017323"],"award-info":[{"award-number":["2020R1A5A2017323"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.omtn.2024.102128","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T22:05:43Z","timestamp":1706047543000},"page":"102128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exosomal noncoding RNA: A potential therapy for retinal vascular diseases"],"prefix":"10.1016","volume":"35","author":[{"given":"Jong-Ik","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-1626","authenticated-orcid":false,"given":"Juhee","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102128_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2011.11.003","article-title":"From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease","volume":"31","author":"Caprara","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2024.102128_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10633-008-9127-8","article-title":"Retinal degenerative and hypoxic ischemic disease","volume":"118","author":"Fulton","year":"2009","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/426769","article-title":"Hypoxia-induced oxidative stress in ischemic retinopathy","volume":"2012","author":"Li","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.omtn.2024.102128_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nature04482","article-title":"Retinal angiogenesis in development and disease","volume":"438","author":"Gariano","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102128_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","article-title":"Retinal vasculature development in health and disease","volume":"63","author":"Selvam","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2024.102128_bib6","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1167\/iovs.10-5176","article-title":"The mouse retina as an angiogenesis model","volume":"51","author":"Stahl","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0070-2153(06)76007-0","article-title":"Regulation of angiogenesis by hypoxia and hypoxia-inducible factors","volume":"76","author":"Hickey","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.omtn.2024.102128_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/13894501113149990015","article-title":"Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases","volume":"14","author":"Vadlapatla","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.omtn.2024.102128_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","article-title":"Ocular neovascularization","volume":"91","author":"Campochiaro","year":"2013","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib10","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1073\/pnas.1320243111","article-title":"Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8","volume":"111","author":"Ahn","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102128_bib11","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1073\/pnas.1101321108","article-title":"VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting","volume":"108","author":"Oladipupo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102128_bib12","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","article-title":"VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells","volume":"124","author":"Grunewald","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102128_bib14","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1167\/iovs.02-1092","article-title":"Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization","volume":"44","author":"Rakic","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib15","first-page":"553","article-title":"Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A","volume":"17","author":"Dong","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.omtn.2024.102128_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mam.2017.10.002","article-title":"PDGF-C and PDGF-D in ocular diseases","volume":"62","author":"Kumar","year":"2018","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1167\/iovs.13-12978","article-title":"Systemic upregulation of PDGF-B in patients with neovascular AMD","volume":"55","author":"Zehetner","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","article-title":"Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor \u03b1, and transforming growth factor \u03b21 in human corneas with neovascularization","volume":"19","author":"Cursiefen","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.omtn.2024.102128_bib19","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.1038\/s41598-017-10124-4","article-title":"TGF-\u03b2 participates choroid neovascularization through Smad2\/3-VEGF\/TNF-\u03b1 signaling in mice with Laser-induced wet age-related macular degeneration","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102128_bib20","first-page":"2627","article-title":"Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in\u00a0vivo","volume":"93","author":"Ribatti","year":"1999","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.omtn.2024.102128_bib21","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.diabres.2007.01.035","article-title":"Novel role of erythropoietin in proliferative diabetic retinopathy","volume":"77","author":"Takagi","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.omtn.2024.102128_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model","volume":"150","author":"P\u00e9rez-Santonja","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41372-022-01489-0","article-title":"Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension","volume":"43","author":"Park","year":"2023","journal-title":"J.\u00a0Perinatol."},{"key":"10.1016\/j.omtn.2024.102128_bib25","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2024.102128_bib26","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2024.102128_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/2474126420930863","article-title":"Occlusive retinal vasculitis following intravitreal brolucizumab","volume":"4","author":"Witkin","year":"2020","journal-title":"J.\u00a0Vitreoretin. Dis."},{"key":"10.1016\/j.omtn.2024.102128_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/OPTH.S207978","article-title":"Issues with intravitreal administration of anti-VEGF drugs","volume":"14","author":"Schargus","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib29","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.2174\/1381612821666150225120314","article-title":"Anti-VEGF drugs in eye diseases: local therapy with potential systemic effects","volume":"21","author":"van der Giet","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.omtn.2024.102128_bib30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41433-018-0021-7","article-title":"Clinical pharmacology of intravitreal anti-VEGF drugs","volume":"32","author":"Fogli","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.omtn.2024.102128_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/eye.2014.13","article-title":"A review of anti-VEGF agents for proliferative diabetic retinopathy","volume":"28","author":"Osaadon","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.omtn.2024.102128_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11892-022-01491-y","article-title":"Systemic and ocular adverse events with intravitreal anti-VEGF therapy used in the treatment of diabetic retinopathy: A review","volume":"22","author":"Zehden","year":"2022","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.omtn.2024.102128_bib33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/IAE.0b013e318042d32c","article-title":"Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review","volume":"27","author":"Fong","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.omtn.2024.102128_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4274\/tjo.75032","article-title":"Comparison of efficacy and side effects of multispot lasers and conventional lasers for diabetic retinopathy treatment","volume":"47","author":"\u00c7eliker","year":"2017","journal-title":"Turk. J. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/014107680309600605","article-title":"Laser management of diabetic retinopathy","volume":"96","author":"Dowler","year":"2003","journal-title":"J.\u00a0R. Soc. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102128_bib37","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","article-title":"Exosomes as mediators of intercellular crosstalk in metabolism","volume":"33","author":"Isaac","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.omtn.2024.102128_bib38","article-title":"Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2024.102128_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.omtn.2024.102128_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.omtn.2024.102128_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","article-title":"Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?","volume":"13","author":"Kou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2024.102128_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: From biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2024.102128_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","article-title":"A review on exosomes application in clinical trials: Perspective, questions, and challenges","volume":"20","author":"Rezaie","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2024.102128_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","article-title":"Exosomes as a new frontier of cancer liquid biopsy","volume":"21","author":"Yu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtn.2024.102128_bib45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2024.102128_bib46","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2024.102128_bib47","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.3390\/cancers13174435","article-title":"Recent advances in exosome-based drug delivery for cancer therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.omtn.2024.102128_bib48","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2024.102128_bib49","article-title":"Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells","volume":"6","author":"Zhu","year":"2017","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2024.102128_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/cells12030356","article-title":"The Role of Exosomes in Human Carcinogenesis and Cancer Therapy\u2014Recent Findings from Molecular and Clinical Research","volume":"12","author":"Stefa\u0144ska","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102128_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2018.11.009","article-title":"Exosomes in inflammation and role as biomarkers","volume":"488","author":"Console","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.omtn.2024.102128_bib52","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/cells11061005","article-title":"The role of exosomes in inflammatory diseases and tumor-related inflammation","volume":"11","author":"Tian","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102128_bib53","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/bph.15432","article-title":"Clinical applications for exosomes: Are we there yet?","volume":"178","author":"Perocheau","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102128_bib54","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102128_bib55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/35103511","article-title":"Non\u2013coding RNA genes and the modern RNA world","volume":"2","author":"Eddy","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2024.102128_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omtn.2024.102128_bib57","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2024.102128_bib58","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00335-008-9136-7","article-title":"Noncoding RNA in development","volume":"19","author":"Amaral","year":"2008","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.omtn.2024.102128_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/path.2638","article-title":"Non-coding RNAs: regulators of disease","volume":"220","author":"Taft","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.omtn.2024.102128_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102128_bib61","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/biom12121774","article-title":"Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017\u20132022)","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtn.2024.102128_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.771552","article-title":"miRNA, lncRNA and circRNA: targeted molecules full of therapeutic prospects in the development of diabetic retinopathy","volume":"12","author":"Chang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.omtn.2024.102128_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14712598.2021.1856365","article-title":"RNA therapeutics for retinal diseases","volume":"21","author":"Gemayel","year":"2021","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.omtn.2021.02.031","article-title":"Targeting non-coding RNAs for the treatment of retinal diseases","volume":"24","author":"Song","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102128_bib65","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.omtn.2022.04.035","article-title":"Exosomal mitochondrial tRNAs and miRNAs as potential predictors of inflammation in renal proximal tubular epithelial cells","volume":"28","author":"Ranches","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102128_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.omtn.2023.01.002","article-title":"tRF-1001: A potential therapeutic target for ocular neovascular diseases","volume":"31","author":"Cingaram","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102128_bib67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.preteyeres.2014.07.003","article-title":"Role of microRNAs in the modulation of diabetic retinopathy","volume":"43","author":"Mastropasqua","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2024.102128_bib68","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-5189","article-title":"MicroRNA and diabetic retinopathy\u2014biomarkers and novel therapeutics","volume":"9","author":"Smit-McBride","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib69","article-title":"The role of MicroRNAs in the pathogenesis of diabetic nephropathy","volume":"2019","author":"Tang","year":"2019","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.omtn.2024.102128_bib70","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4103\/1673-5374.259602","article-title":"MicroRNAs as biomarkers of diabetic retinopathy and disease progression","volume":"14","author":"Martinez","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.omtn.2024.102128_bib71","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/mt.2008.104","article-title":"MicroRNAs regulate ocular neovascularization","volume":"16","author":"Shen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.yexmp.2011.04.016","article-title":"MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors","volume":"91","author":"Bai","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.omtn.2024.102128_bib73","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3390\/jcm11061484","article-title":"AMD genomics: Non-coding RNAs as biomarkers and therapeutic targets","volume":"11","author":"Zhang","year":"2022","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib74","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/ijms24032636","article-title":"Non-Coding RNAs Regulating Mitochondrial Functions and the Oxidative Stress Response as Putative Targets against Age-Related Macular Degeneration (AMD)","volume":"24","author":"Hyttinen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib75","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/02713683.2020.1857778","article-title":"LncRNA-MALAT1\/miRNA-204-5p\/Smad4 Axis Regulates Epithelial\u2013Mesenchymal Transition, Proliferation and Migration of Lens Epithelial Cells","volume":"46","author":"Peng","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.omtn.2024.102128_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107886","article-title":"Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K\/Akt\/VEGF signaling pathway in diabetic retinopathy","volume":"190","author":"Lu","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2024.102128_bib77","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1080\/21655979.2021.1964895","article-title":"The up-regulation of miR-21 by gastrodin to promote the angiogenesis ability of human umbilical vein endothelial cells by activating the signaling pathway of PI3K\/Akt","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.omtn.2024.102128_bib78","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.tig.2016.03.002","article-title":"Circular RNA expression: its potential regulation and function","volume":"32","author":"Salzman","year":"2016","journal-title":"Trends Genet."},{"key":"10.1016\/j.omtn.2024.102128_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","article-title":"Circular RNA: a new star of noncoding RNAs","volume":"365","author":"Qu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omtn.2024.102128_bib80","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/1535370217708978","article-title":"Circular RNA\u2013new member of noncoding RNA with novel functions","volume":"242","author":"Hsiao","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","article-title":"Circular RNA and its mechanisms in disease: from the bench to the clinic","volume":"187","author":"Han","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib82","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/15476286.2016.1271524","article-title":"Insights into circular RNA biology","volume":"14","author":"Ebbesen","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2024.102128_bib83","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The landscape of circular RNA in cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102128_bib84","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1002\/jcp.27384","article-title":"Circular RNA in cardiovascular disease","volume":"234","author":"Altesha","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.omtn.2024.102128_bib85","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtn.2024.102128_bib86","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.omtn.2021.05.022","article-title":"Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential","volume":"25","author":"Sharma","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102128_bib87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.omtn.2021.12.031","article-title":"Circular RNA circSmoc1-2 regulates vascular calcification by acting as a miR-874-3p sponge in vascular smooth muscle cells","volume":"27","author":"Ryu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102128_bib88","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1007\/s12035-016-0213-8","article-title":"Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases","volume":"54","author":"Kumar","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.omtn.2024.102128_bib89","first-page":"16","article-title":"Circular non-coding RNAs in diabetic retinopathy","volume":"1","author":"Diekmann","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.omtn.2024.102128_bib90","first-page":"4427","article-title":"MiR-7 regulates the PI3K\/AKT\/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation","volume":"22","author":"Cao","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib91","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102128_bib92","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2024.102128_bib93","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","article-title":"Cellular functions of long noncoding RNAs","volume":"21","author":"Yao","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102128_bib94","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/ijms17040478","article-title":"Novel insights into the role of long noncoding RNA in ocular diseases","volume":"17","author":"Li","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00417-022-05843-y","article-title":"Long non-coding RNAS in retinal neovascularization: Current research and future directions","volume":"261","author":"Cao","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib96","article-title":"Long non-coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling","volume":"14","author":"Yao","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib97","article-title":"Non-coding RNAs regulate angiogenic processes","volume":"133\u2013134","author":"Ghafouri-Fard","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102128_bib98","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","article-title":"Extracellular vesicles in immunomodulation and tumor progression","volume":"22","author":"Marar","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2024.102128_bib99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/dna.2016.3496","article-title":"Characteristics and roles of exosomes in cardiovascular disease","volume":"36","author":"Zhang","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.omtn.2024.102128_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbadis.2014.10.008","article-title":"Pathologic function and therapeutic potential of exosomes in cardiovascular disease","volume":"1852","author":"Ailawadi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2024.102128_bib101","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3390\/diagnostics10110943","article-title":"Exosomes in cardiovascular diseases","volume":"10","author":"Zar\u00e0","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.omtn.2024.102128_bib102","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib103","article-title":"Dendritic cells derived exosomes migration to spleen and induction of inflammation are regulated by CCR7","volume":"7","author":"Wei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102128_bib104","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41467-019-12321-3","article-title":"CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity","volume":"10","author":"Fu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102128_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201802219","article-title":"CD4+ T Cell-Released Extracellular Vesicles Potentiate the Efficacy of the HBsAg Vaccine by Enhancing B Cell Responses","volume":"6","author":"Lu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib106","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.7150\/thno.18752","article-title":"Exosomes derived from natural killer cells exert therapeutic effect in melanoma","volume":"7","author":"Zhu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2024.102128_bib107","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2024.102128_bib108","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cell"},{"key":"10.1016\/j.omtn.2024.102128_bib109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41409-019-0616-z","article-title":"Mesenchymal stem cell-derived exosomes for clinical use","volume":"54","author":"Mendt","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtn.2024.102128_bib110","article-title":"BMSC-Derived Exosomes Alleviate Sepsis-Associated Acute Respiratory Distress Syndrome by Activating the Nrf2 Pathway to Reverse Mitochondrial Dysfunction","volume":"2023","author":"Li","year":"2023","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.omtn.2024.102128_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202205692","article-title":"Exosome-Based Mitochondrial Delivery of circRNA mSCAR Alleviates Sepsis by Orchestrating Macrophage Activation","volume":"10","author":"Fan","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib112","first-page":"485","article-title":"Human Bone mesenchymal stem cell-derived exosomes inhibit IL-1\u03b2-induced inflammation in osteoarthritis chondrocytes","volume":"23","author":"Zhou","year":"2021","journal-title":"Cell J."},{"key":"10.1016\/j.omtn.2024.102128_bib113","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/jcmm.17727","article-title":"Human serum-derived exosomes modulate macrophage inflammation to promote VCAM1-mediated angiogenesis and bone regeneration","volume":"27","author":"Xiang","year":"2023","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib114","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1242\/jcs.170373","article-title":"Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a","volume":"129","author":"Liang","year":"2016","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib115","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cell Dev."},{"key":"10.1016\/j.omtn.2024.102128_bib116","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14712598.2020.1689954","article-title":"Therapeutic potential of mesenchymal stem\/stromal cell-derived secretome and vesicles for lung injury and disease","volume":"20","author":"Liu","year":"2020","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib117","first-page":"e922782","article-title":"Extracellular vesicles derived from adipose mesenchymal stem cells alleviate PM2. 5-induced lung injury and pulmonary fibrosis","volume":"26","author":"Gao","year":"2020","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.omtn.2024.102128_bib118","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13287-022-02900-5","article-title":"Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study","volume":"13","author":"Zhu","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib119","doi-asserted-by":"crossref","DOI":"10.4103\/ijpvm.ijpvm_441_21","article-title":"Safety of intraparenchymal injection of allogenic placenta mesenchymal stem cells derived exosome in patients undergoing decompressive craniectomy following malignant middle cerebral artery infarct, a pilot randomized clinical trial","volume":"13","author":"Dehghani","year":"2022","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12964-023-01227-9","article-title":"Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2024.102128_bib121","first-page":"1","article-title":"The Role of Small Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Myocardial Protection: a Review of Current Advances and Future Perspectives","author":"Wu","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib122","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s13770-021-00334-3","article-title":"Mesenchymal stem cell transplantation for ischemic diseases: mechanisms and challenges","volume":"18","author":"Van Nguyen","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib123","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4252\/wjsc.v15.i7.665","article-title":"Human retinal secretome: A cross-link between mesenchymal and retinal cells","volume":"15","author":"Donato","year":"2023","journal-title":"World J. Stem Cell."},{"key":"10.1016\/j.omtn.2024.102128_bib124","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.3390\/ijms24119356","article-title":"The Potential of MSC-Based Cell-Free Therapy in Wound Healing\u2014A Thorough Literature Review","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj9617","article-title":"miR-204\u2013containing exosomes ameliorate GVHD-associated dry eye disease","volume":"8","author":"Zhou","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2024.102128_bib126","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221133818","article-title":"Mesenchymal Stromal Cell\u2013Based Therapy for Dry Eye: Current Status and Future Perspectives","volume":"31","author":"Jiang","year":"2022","journal-title":"Cell Transplant."},{"key":"10.1016\/j.omtn.2024.102128_bib127","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/stcltm\/szad051","article-title":"Management of Retinitis Pigmentosa Via Wharton\u2019s Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results","volume":"12","author":"Ozmert","year":"2023","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.omtn.2024.102128_bib128","first-page":"223","article-title":"Mesenchymal stem cell surgery, rescue and regeneration in retinitis pigmentosa: clinical and rehabilitative prognostic aspects","volume":"38","author":"Limoli","year":"2020","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.omtn.2024.102128_bib129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/5584_2018_219","article-title":"Therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of eye diseases","volume":"1089","author":"Harrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtn.2024.102128_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107899","article-title":"Therapeutic effects of mesenchymal stem cell-derived exosomes on retinal detachment","volume":"191","author":"Ma","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2024.102128_bib131","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00417-018-4097-3","article-title":"Effects of mesenchymal stem cells and their exosomes on the healing of large and refractory macular holes","volume":"256","author":"Zhang","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib132","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/s41598-017-04559-y","article-title":"Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis","volume":"7","author":"Bai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102128_bib133","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102128_bib134","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/medicina59091599","article-title":"Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic","volume":"59","author":"Yan","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.omtn.2024.102128_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj7002","article-title":"Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity","volume":"8","author":"Kamerkar","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2024.102128_bib136","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/aos.14932","article-title":"Advances in exosome therapies in ophthalmology\u2013From bench to clinical trial","volume":"100","author":"Sanghani","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.935244","article-title":"Research progress on exosomes\/microRNAs in the treatment of diabetic retinopathy","volume":"13","author":"Niu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.omtn.2024.102128_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114899","article-title":"Advances in development of exosomes for ophthalmic therapeutics","volume":"199","author":"Tian","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2024.102128_bib139","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.3390\/ijms24109006","article-title":"Extracellular-Vesicle-Based Therapeutics in Neuro-Ophthalmic Disorders","volume":"24","author":"Massoumi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib140","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1042\/CS20190188","article-title":"Endothelial progenitor cell-derived exosomes facilitate vascular endothelial cell repair through shuttling miR-21-5p to modulate Thrombospondin-1 expression","volume":"133","author":"Hu","year":"2019","journal-title":"Clin. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib141","first-page":"35","article-title":"Extracellular vesicles participate in the transport of cytokines and angiogenic factors in diabetic patients with ocular complications","volume":"55","author":"Tokarz","year":"2015","journal-title":"Folia Med. Cracov."},{"key":"10.1016\/j.omtn.2024.102128_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106135","article-title":"Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications","volume":"178","author":"Xu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omtn.2024.102128_bib143","doi-asserted-by":"crossref","first-page":"e18626","DOI":"10.1016\/j.heliyon.2023.e18626","article-title":"Exosomal non-coding RNAs in angiogenesis: Functions, mechanisms and potential clinical applications","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.omtn.2024.102128_bib144","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/antiox9080705","article-title":"Extracellular vesicles and MicroRNA: putative role in diagnosis and treatment of diabetic retinopathy","volume":"9","author":"Martins","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.omtn.2024.102128_bib145","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1089\/ars.2016.6844","article-title":"Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress","volume":"27","author":"Tengku","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.omtn.2024.102128_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108271","article-title":"Retinal pigment epithelial cells secrete miR-202-5p-containing exosomes to protect against proliferative diabetic retinopathy","volume":"201","author":"Gu","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2024.102128_bib147","article-title":"Serum exosomal miR-377-3p inhibits retinal pigment epithelium proliferation and offers a biomarker for diabetic macular edema","volume":"49","author":"Jiang","year":"2021","journal-title":"J.\u00a0Int. Med. Res."},{"key":"10.1016\/j.omtn.2024.102128_bib149","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1167\/iovs.17-22698","article-title":"Identification and Characterization of Circular RNAs as a New Class of Putative Biomarkers in Diabetes Retinopathy","volume":"58","author":"Zhang","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib150","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1814874116","article-title":"Targeting pericyte-endothelial cell crosstalk by circular RNA-cPWWP2A inhibition aggravates diabetes-induced microvascular dysfunction","volume":"116","author":"Liu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102128_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119232","article-title":"MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p\/XBP1 axis","volume":"272","author":"Cao","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib152","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.omtn.2019.04.029","article-title":"Exosomes from Microglia Attenuate Photoreceptor Injury and Neovascularization in an Animal Model of Retinopathy of Prematurity","volume":"16","author":"Xu","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102128_bib155","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.kint.2016.07.015","article-title":"Transfer of microRNA-486-5p from human endothelial colony forming cell\u2013derived exosomes reduces ischemic kidney injury","volume":"90","author":"Vi\u00f1as","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2024.102128_bib153","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/00365513.2019.1637931","article-title":"Three new circulating microRNAs may be associated with wet age-related macular degeneration","volume":"79","author":"Elbay","year":"2019","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.omtn.2024.102128_bib158","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1167\/iovs.18-25617","article-title":"Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to Ameliorate Hyperglycemia-Induced Retinal Inflammation Via Targeting HMGB1","volume":"60","author":"Zhang","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib159","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13287-020-02064-0","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial-mesenchymal transition by targeting HOXC6","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib160","first-page":"559","article-title":"Mesenchymal stem cells-derived exosomes ameliorate blue light stimulation in retinal pigment epithelium cells and retinal laser injury by VEGF-dependent mechanism","volume":"11","author":"He","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102128_bib148","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2024.102128_bib154","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2013.12.003","article-title":"Myostatin signaling regulates Akt activity via the regulation of miR-486 expression","volume":"47","author":"Hitachi","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102128_bib156","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2024.102128_bib157","article-title":"Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102128_bib161","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2024.102128_bib162","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering exosomes as refined biological nanoplatforms for drug delivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.omtn.2024.102128_bib163","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12265-019-09952-8","article-title":"Infarct Zone: a Novel Platform for Exosome Trade in Cardiac Tissue Regeneration","volume":"13","author":"Thankam","year":"2020","journal-title":"J.\u00a0Cardiovasc. Transl. Res."},{"key":"10.1016\/j.omtn.2024.102128_bib164","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40259-020-00434-x","article-title":"Designer Exosomes: A New Platform for Biotechnology Therapeutics","volume":"34","author":"Jafari","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtn.2024.102128_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100261","article-title":"Exosome engineering: Current progress in cargo loading and targeted delivery","volume":"20","author":"Fu","year":"2020","journal-title":"NanoImpact"},{"key":"10.1016\/j.omtn.2024.102128_bib166","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","article-title":"Exosome engineering in cell therapy and drug delivery","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.omtn.2024.102128_bib167","article-title":"Engineered Exosomes With Ischemic Myocardium-Targeting Peptide for Targeted Therapy in Myocardial Infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.omtn.2024.102128_bib168","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/jbm.a.36959","article-title":"Impact of exosome-loaded chitosan hydrogel in wound repair and layered dermal reconstitution in mice animal model","volume":"108","author":"Nooshabadi","year":"2020","journal-title":"J.\u00a0Biomed. Mater. Res."},{"key":"10.1016\/j.omtn.2024.102128_bib169","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1002\/adfm.201601430","article-title":"Bioengineered Extracellular Membranous Nanovesicles for Efficient Small-Interfering RNA Delivery: Versatile Platforms for Stem Cell Engineering and In\u00a0Vivo Delivery","volume":"26","author":"Jin","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.omtn.2024.102128_bib170","first-page":"1332","article-title":"Engineering exosomes: a new direction for anticancer treatment","volume":"8","author":"You","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.omtn.2024.102128_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061122","article-title":"Engineering Exosomes for Cancer Therapy","volume":"18","author":"Gilligan","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102128_bib172","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.7150\/thno.62330","article-title":"Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2024.102128_bib173","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11095-017-2123-5","article-title":"Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading","volume":"34","author":"Sutaria","year":"2017","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.omtn.2024.102128_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020598","article-title":"Exosome-Based Carrier for RNA Delivery: Progress and Challenges","volume":"15","author":"Lu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2024.102128_bib175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","article-title":"Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102128_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109969","article-title":"MicroRNA-29 specifies age-related differences in the CD8+ T\u00a0cell immune response","volume":"37","author":"Yee Mon","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2024.102128_bib177","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102128_bib178","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13045-020-00987-y","article-title":"Isolation and characterization of exosomes for cancer research","volume":"13","author":"Zhu","year":"2020","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.omtn.2024.102128_bib179","article-title":"Genetically Engineered Liposome-like Nanovesicles as Active Targeted Transport Platform","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2024.102128_bib180","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2021.04.036","article-title":"Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses","volume":"161","author":"Zhao","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtn.2024.102128_bib181","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1158\/0008-5472.CAN-09-3276","article-title":"Dendritic cell-derived exosomes for cancer immunotherapy: what's next?","volume":"70","author":"Viaud","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2024.102128_bib182","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/mt.2012.161","article-title":"Genetically engineered microvesicles carrying suicide mRNA\/protein inhibit schwannoma tumor growth","volume":"21","author":"Mizrak","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102128_bib183","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","article-title":"Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy","volume":"150","author":"Tian","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2024.102128_bib184","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.2147\/IJN.S277190","article-title":"Roles of exosomes in ocular diseases","volume":"15","author":"Liu","year":"2020","journal-title":"Int. J. Nanomed."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:44:55Z","timestamp":1760856295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":184,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2162253124000155"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102128","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal noncoding RNA: A potential therapy for retinal vascular diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"102128"}}